Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation

Presentation ESC 2024

OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation

Presenter: Manesh R. Patel

September 01, 2024

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Presentation ESC 2024

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Presenter: Gi-Byoung Nam

September 01, 2024

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

Presentation

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

August 20, 2019

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticouagulants

Presentation ACC 2018

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticoagulants

Presenter: Steve Deitelzweig

March 12, 2018

Use of NOAC in Coronary Artery Disease

Presentation TTT 2018

Use of NOAC in Coronary Artery Disease

Presenter: Tsung-Hsien Lin

January 14, 2018

Warfarin and NOACs in Non-Valvular Atrial Fibrillation

Presentation LAA 2017

Warfarin and NOACs in Non-Valvular Atrial Fibrillation

Presenter: Gregg W. Stone

July 21, 2017

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

Presentation

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

May 23, 2017

Appendix Closure is the Solution

Presentation JIM 2017

Appendix Closure is the Solution

Presenter: Horst Sievert

February 10, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.